Everything below concerns thymosin alpha-1. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
=== Psychomotor effects === The most common effect is fatigue or somnolence, particularly in older adults, although patients with pre-existing daytime sleepiness and fatigue may experience paradoxical improvement of these symptoms. Escitalopram has not been shown to affect serial reaction time, logical reasoning, serial subtraction, multitasking, or Mackworth Clock task performance.
Foods are dried to inhibit microbial development and quality decay. However, the extent of drying depends on product end-use. Cereals and oilseeds are dried after harvest to the moisture content that allows microbial stability during storage. Vegetables are blanched before drying to avoid rapid darkening, and drying is not only carried out to inhibit microbial growth, but also to avoid browning during storage. Concerning dried fruits, the reduction of moisture acts in combination with its acid and sugar contents to provide protection against microbial growth. Products such as milk powder must be dried to very low moisture contents in order to ensure flowability and avoid caking. This moisture is lower than that required to ensure inhibition to microbial development. Other products as crackers are dried beyond the microbial growth threshold to confer a crispy texture, which is liked by consumers.
Peruvian diplomacy based its principles on continental solidarity (product of Pan-Americanism) and the defense of national sovereignty and integrity, especially the Amazonian ambitions of Brazilian interests and their expansionist advances, which were now related to the Argentines. Evidence of the public condemnation of Peru towards this policy of conquest, by the Brazilians and Argentines against Paraguay, was shown in an edition of the newspaper El Comercio, dated 10/8/1866, which responded to accusations of the anti-Peruvian Argentine press that there was a lack of impartiality in the country due to Peru's sympathy with Paraguay. Given this Peruvian support to Paraguayans, Argentina reacted with anti-Peruvian positions, refusing to be a country a member of the Quadruple Alliance against Spain in the War of the Chincha Islands; In addition, the diplomacy practiced by the Triple Alliance sought to separate the Pacific governments (Chile, Peru, Bolivia and Ecuador) and thus dissolve the Quadruple Alliance. Regarding possible profitable differences, Bolivia was definitely the most vulnerable country, being a priority for Argentine diplomacy. Thus, Argentine and Uruguayan agents tried to seduce the Bolivians, telling them that the scope of the quadruple alliance treaty was not justified, while there were Bolivian territorial claims against the Peruvians and Chileans that the Bolivians still feared would not be able to defend them.
== Treatment == The treatment aims to create an environment that allows skin to grow across an ulcer. In most cases, this requires finding and treating underlying venous reflux. The National Institute for Health and Care Excellence (NICE) recommends referral to a vascular service for anyone with a leg ulcer that has not healed within two weeks or anyone with a healed leg ulcer. Most venous ulcers respond to patient education, elevation of the foot, elastic compression, and evaluation (known as the Bisgaard regimen). Exercise together with compression stocking increases healing. There is no evidence that antibiotics, whether administered intravenously or by mouth, are useful. Silver products are also not typically useful, while there is some evidence of benefit from cadexomer iodine creams. There is a lack of quality evidence regarding the use of medical-grade honey for venous leg ulcers. The recommendations for dressings to treat venous ulcers vary between the countries. Antibiotics are often recommended to be used only if advised by the physician due to the emergence of bacterial resistance to antibiotics. This is an issue with venous ulcers as they tend to heal more slowly than acute wounds, for example. Natural alternatives that are suitable for long-term use exist on the market, such as honey and resin salve. These products are considered as Medical Devices in EU and the products have to be CE marked. Sugar has long been known for its effectiveness in wound treatment, notably through the use of honey or powdered sugar.
=== Post-processing === In the post-processing phase, printed food may require additional steps before consumption. This includes processing activities such as baking, frying, cleaning, etc. This phase can be one of the most critical to 3D printed food, as the printed food needs to be safe for consumption. An additional concern in post processing is the deformation of the printed food due to the strain of these additional processes. Current methods involve trial and error. That is, combining food additives with the materials/ingredients to improve the integrity of complex structures and to ensure the printed structure retains its shape. Additives such as transglutaminase and hydrocolloids have been added to ingredients in order to help retain the printed shape while printing and after cooking. Additionally, recent research has produced a visual simulation for baking breads, cookies, pancakes and similar materials that consist of dough or batter (mixtures of water, flour, eggs, fat, sugar and leavening agents). By adjusting certain parameters in the simulation, it shows the realistic effect that baking will have on the food. With further research and development, a visual simulation of 3D printed foods being cooked could predict what is vulnerable to deformation.
Sources: en.wikipedia.org
==== Medieval photography ==== The art historian Nicholas Allen has proposed that the image on the shroud could have been formed as early as the 13th century using techniques described in the 1011 Book of Optics. However, according to Mike Ware, a chemist and expert on the history of photography, Allen's proposal "encounters serious obstacles with regard to the technical history of the lens. Such claimants tend to draw upon the wisdom of hindsight to project a distorted historical perspective, wherein their cases rest upon a particular concatenation of procedures which is exceedingly improbable; and their 'proofs' amount only to demonstrating (none too faithfully) that it was not totally impossible." Among other difficulties, Allen's hypothesized process would have required that the subject (a corpse) be exposed in the sunlight for months.
== Further reading == Verma, S; Bhargava, M; Mittal, SK; Gupta, R (1 January 2013). "Homozygous delta-beta Thalassemia in a Child: a Rare Cause of Elevated Fetal Hemoglobin". Iranian Journal of Pediatric Hematology and Oncology. 3 (1): 222–227. ISSN 2008-8892. PMC 3915439. PMID 24575268. Kumar, B. Vinodh; Choccalingam, Chidambharam; Samuel, Premila (1 March 2016). "Incidental Identification of Possible Delta-Beta Thalassemia Trait in a Family: A Rare Cause of Elevated Hb F." Journal of Clinical and Diagnostic Research. 10 (3): BD01–BD02. doi:10.7860/JCDR/2016/16352.7409. ISSN 2249-782X. PMC 4843246. PMID 27134860. "Public Health Information Network Vocabulary Access and Distribution System (PHIN VADS)". CDC. Centers for Disease Control. Retrieved 17 September 2016.
=== Negative factors === Diabetes, cardiovascular disease, urgent initiation, inadequate dialysis (Kt/V <1.2), infections. COVID-19 increased mortality in 2020 but rates declined by 2022. In low-resource settings, median survival may be ~1.5 years due to access barriers.
"In 1946, Students protested that the anniversary of the founding of the Arab league had not been made a public holiday". The most serious problem facing Aden in the late 50s and 60s was the relationship with the Yemen and Yemeni raids along the borders. But the adherence of Yemen to the UAR created a delicate situation and several political problems arose. Immigration into the Colony was a major concern of the local Arab workforce. Previously to the creation of the UAR, peace in Aden it was admitted came not from the presence of the tiny garrison, but from a lack of Arab poles of attraction for malcontents. However some contemporary writers, such as Elizabeth Monroe thought that the British presence in Aden may have been self-defeating, as it provided a casus belli for Arab nationalists. So rather than supporting British peace efforts in the region, Aden was actually the cause of much anti-British sentiments in the region. "As in Kuwait prosperous older men appreciate the advantages of the British connection, but young Arab nationalists and a vigorous trade union movement think it humiliating".
Sources: en.wikipedia.org
=== Monoclonal antibodies targeting the CGRP molecule === Eptinezumab (ALD403) is approved for prevention of migraine. Fremanezumab (TEV-48125) is approved for prevention of migraine. Galcanezumab (LY2951742) is approved for prevention of migraine and cluster headaches.
Portugal is a high-income country with an advanced economy that follows the Mediterranean model. The country's economic policy is framed by strategic guidelines called Major Options, which are subsequently implemented through the State Budget. Portugal has the EU's 14th-largest economy by nominal GDP and the 12th-largest economy by PPP-adjusted GDP. Its PPP-adjusted GDP per capita stood at to 81% of the EU average in 2025. As of 2024, Portugal's service sector contributed the most for its economic output followed the industrial sector and its primary sector. In 2025, Portugal unemployment rate was 5.8%. As of 2024, its poverty rate after social transfers was 15.4% of the population while in 2023, the at-risk-of-poverty rate before social transfers stood at 40.3%. The national debt of Portugal was estimated at 89.2% relative to GDP as of 2025. Portugal is part of the European single market which represents more than 450 million consumers. Portugal replaced the escudo with the euro in 2002. Its monetary policy is set by the European Central Bank. The country has been a part of the Eurozone since its inception. Portugal's central bank is the Banco de Portugal and it is part of the European System of Central Banks. In 2024, Portugal had a combined share of exports and imports that amounted to 90% of its total GDP. In February 2026, Portugal's main export markets were Spain at 26% and Germany at 13.9%. Its main exports are machinery and mechanical appliances, vehicles and other transportation equipment, base metals, and plastics.
Cannabis strains is a popular name to refer to plant varieties of the monospecific genus Cannabis sativa L.. They are either pure or hybrid varieties of the plant, which encompasses various sub-species C. sativa, C. indica, and C. ruderalis. Varieties are developed to intensify specific characteristics of the plant, or to differentiate the strain for the purposes of marketing or to make it more effective as a drug. Variety names are typically chosen by their growers, and often reflect properties of the plant such as taste, color, smell, or the origin of the variety. The Cannabis strains referred to in this article are primarily those varieties with recreational and medicinal use. These varieties have been cultivated to contain a high percentage of cannabinoids. Several varieties of cannabis, known as hemp, have a very low cannabinoid content, and are instead grown for their fiber and seed. Due to the legal status of the plant in many jurisdictions, Cannabis plant varieties are at high risk of biopiracy.
genetic engineering Also genetic modification or genetic manipulation. The direct, deliberate manipulation of an organism's genetic material using any of a variety of biotechnology methods, including the insertion or removal of genes, the transfer of genes within and between species, the mutation of existing sequences, and the construction of novel sequences using artificial gene synthesis. Genetic engineering encompasses a broad set of technologies by which the genetic composition of individual cells, tissues, or entire organisms may be altered for various purposes, commonly in order to study the functions and expression of individual genes, to produce hormones, vaccines, and other drugs, and to create genetically modified organisms for use in research and agriculture.
Kissinger and Nixon both disliked the idea of a "standstill ceasefire," as they felt it would weaken South Vietnam, but fearing the possibility of Nixon not being reelected in 1972 if he were to continue on his present course, the offer was seen as worth the risk, especially since the North Vietnamese rejected it. In private, Kissinger called the "standstill ceasefire" offer as the means that "at a minimum...would give us from temporary relief from public pressures". Subsequently, Kissinger has maintained that Nixon's offer of 7 October was sincere and that the North Vietnamese made a major error in rejecting it.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.